284 related articles for article (PubMed ID: 19617399)
1. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.
Myerburg MM; King JD; Oyster NM; Fitch AC; Magill A; Baty CJ; Watkins SC; Kolls JK; Pilewski JM; Hallows KR
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):676-84. PubMed ID: 19617399
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation.
Hallows KR; Fitch AC; Richardson CA; Reynolds PR; Clancy JP; Dagher PC; Witters LA; Kolls JK; Pilewski JM
J Biol Chem; 2006 Feb; 281(7):4231-41. PubMed ID: 16361706
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.
Woollhead AM; Sivagnanasundaram J; Kalsi KK; Pucovsky V; Pellatt LJ; Scott JW; Mustard KJ; Hardie DG; Baines DL
Br J Pharmacol; 2007 Aug; 151(8):1204-15. PubMed ID: 17603555
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells.
Klein H; Garneau L; Trinh NT; Privé A; Dionne F; Goupil E; Thuringer D; Parent L; Brochiero E; Sauvé R
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C285-95. PubMed ID: 19052260
[TBL] [Abstract][Full Text] [Related]
5. AICAR activates AMPK and alters PIP2 association with the epithelial sodium channel ENaC to inhibit Na+ transport in H441 lung epithelial cells.
Mace OJ; Woollhead AM; Baines DL
J Physiol; 2008 Sep; 586(18):4541-57. PubMed ID: 18669532
[TBL] [Abstract][Full Text] [Related]
6. AICAR decreases the activity of two distinct amiloride-sensitive Na+-permeable channels in H441 human lung epithelial cell monolayers.
Albert AP; Woollhead AM; Mace OJ; Baines DL
Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L837-48. PubMed ID: 18723760
[TBL] [Abstract][Full Text] [Related]
7. Phenformin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) activation of AMP-activated protein kinase inhibits transepithelial Na+ transport across H441 lung cells.
Woollhead AM; Scott JW; Hardie DG; Baines DL
J Physiol; 2005 Aug; 566(Pt 3):781-92. PubMed ID: 15919715
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.
Li H; Thali RF; Smolak C; Gong F; Alzamora R; Wallimann T; Scholz R; Pastor-Soler NM; Neumann D; Hallows KR
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F167-77. PubMed ID: 20462973
[TBL] [Abstract][Full Text] [Related]
9. Liquid movement across the surface epithelium of large airways.
Chambers LA; Rollins BM; Tarran R
Respir Physiol Neurobiol; 2007 Dec; 159(3):256-70. PubMed ID: 17692578
[TBL] [Abstract][Full Text] [Related]
10. Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells.
Hallows KR; McCane JE; Kemp BE; Witters LA; Foskett JK
J Biol Chem; 2003 Jan; 278(2):998-1004. PubMed ID: 12427743
[TBL] [Abstract][Full Text] [Related]
11. Effect of neutrophil elastase and its inhibitor EPI-hNE4 on transepithelial sodium transport across normal and cystic fibrosis human nasal epithelial cells.
Prulière-Escabasse V; Clerici C; Vuagniaux G; Coste A; Escudier E; Planès C
Respir Res; 2010 Oct; 11(1):141. PubMed ID: 20932306
[TBL] [Abstract][Full Text] [Related]
12. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770.
Van Goor F; Hadida S; Grootenhuis PD; Burton B; Cao D; Neuberger T; Turnbull A; Singh A; Joubran J; Hazlewood A; Zhou J; McCartney J; Arumugam V; Decker C; Yang J; Young C; Olson ER; Wine JJ; Frizzell RA; Ashlock M; Negulescu P
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18825-30. PubMed ID: 19846789
[TBL] [Abstract][Full Text] [Related]
13. Capsaicinoids regulate airway anion transporters through Rho kinase- and cyclic AMP-dependent mechanisms.
Hibino Y; Morise M; Ito Y; Mizutani T; Matsuno T; Ito S; Hashimoto N; Sato M; Kondo M; Imaizumi K; Hasegawa Y
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):684-91. PubMed ID: 21474433
[TBL] [Abstract][Full Text] [Related]
14. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
15. The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+ channel.
Gentzsch M; Dang H; Dang Y; Garcia-Caballero A; Suchindran H; Boucher RC; Stutts MJ
J Biol Chem; 2010 Oct; 285(42):32227-32. PubMed ID: 20709758
[TBL] [Abstract][Full Text] [Related]
16. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.
Pieri M; Christian HC; Wilkins RJ; Boyd CA; Meredith D
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G136-43. PubMed ID: 20430871
[TBL] [Abstract][Full Text] [Related]
17. Transgenic hCFTR expression fails to correct β-ENaC mouse lung disease.
Grubb BR; O'Neal WK; Ostrowski LE; Kreda SM; Button B; Boucher RC
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L238-47. PubMed ID: 22003093
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin regulates the phosphorylation state of AMP-activated protein kinase (AMPK) in MDCK-C7 cells.
Nofziger C; Kalsi K; West TA; Baines D; Blazer-Yost BL
Cell Physiol Biochem; 2008; 22(5-6):487-96. PubMed ID: 19088430
[TBL] [Abstract][Full Text] [Related]
19. Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance.
Itani OA; Chen JH; Karp PH; Ernst S; Keshavjee S; Parekh K; Klesney-Tait J; Zabner J; Welsh MJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10260-5. PubMed ID: 21646513
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
Kunzelmann K; Mall M
Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
